Drug profile · INN
agalsidase beta
FABRAZYME
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
agalsidase beta (FABRAZYME) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
INN agalsidase beta
Brand FABRAZYME
Route INTRAVENOUS
Formulation VIAL
ATC code A16AB04
Frequently asked questions
What is agalsidase beta?
agalsidase beta (FABRAZYME) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for agalsidase beta?
FABRAZYME is a marketed brand name for agalsidase beta. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of agalsidase beta?
agalsidase beta has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.